Previous studies suggests that the combination of DAC and ATRA synergistically induces apoptosis, growth inhibition, and differentiation of AML cells by inducing the expression of anti-tumour genes [28] and modulating the miR-34a/MYCN axis in vitro [25]. The gene discussed is MYCN; the disease is acute myeloid leukemia.